Weill Cornell awarded $17.4M grant to develop shorter TB treatment regimen
September 17, 2026
September 17, 2026
ITHACA, New York, Sept. 17 -- Cornell University posted the following news:
* * *
Weill Cornell awarded $17.4M grant to develop shorter TB treatment regimen
*
Researchers at Weill Cornell Medicine have received a $17.4 million, five-year grant from the National Institute of Allergy and Infectious Diseases to discover new approaches to shorten tuberculosis (TB) treatment, potentially making it easier for patients to complete therapy. The researc . . .
* * *
Weill Cornell awarded $17.4M grant to develop shorter TB treatment regimen
*
Researchers at Weill Cornell Medicine have received a $17.4 million, five-year grant from the National Institute of Allergy and Infectious Diseases to discover new approaches to shorten tuberculosis (TB) treatment, potentially making it easier for patients to complete therapy. The researc . . .